^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Small Intestinal Carcinoma |
| Drug: | albumin-bound paclitaxel (Bcl2 inhibitor, Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
…taxane-based chemotherapy is a recommended option for second- or subsequent-line therapy, although only nab-paclitaxel has prospective, published data to support its use for treatment of SBA.
